The aim of the present study was to assess the role that NOX-dependent ROS and NETs play in cerebral microvascular thrombosis and whether targeting PAD4/NOX affords protection against thrombotic events associated with thromboinflammatory conditions such as SCD. This evidence concerns the gene PADI4 and deep vein thrombosis.